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EDITORIAL

The Tubulointerstitium: Dark Matter

R

elegated to a less glamorous position than the glomerulonephritides, the tubulointerstitial compartment or
tubulointerstitium of the kidney has been the dark matter
of the kidney universe.1 In the same fashion that dark matter predominates over atomic matter, the tubulointerstitium does so over the glomerular compartment. In fact,
dark matter and the tubulointerstitium hold their respective universes together. In this issue, some of the mysteries
of kidney dark matter are revealed by Cynthia Nast and
the authors she has enlisted. The tubulointerstitial
compartment is featured, and several of its many aspects
are brought into the light.
Interstitial nephritis or more properly tubulointerstitial
nephritis (TIN) is common, yet still underdiagnosed.
Indeed, hypertensive nephrosclerosis is the most common
tubulointerstitial disorder. Long-term assault by uncontrolled hypertension induces rarefaction of peritubular
capillaries, with subsequent attenuation of sodium excretion and an ongoing cycle of hypertension, impaired sodium excretion, and volume-dependent hypertension.
This capillary rarefaction phenomenon is recapitulated
in the ischemia-reperfusion model of rat acute kidney
injury established by Basile.2 In terms of adult acute kidney injury (AKI), acute TIN accounts for 10–27% of cases
examined by kidney biopsy,3 following the two foremost
etiologies of hospital-acquired AKI, prerenal azotemia
and acute tubular necrosis.
The classiﬁcation of acute TIN is straightforward and
can be conveniently used at the bedside. Most instances
of acute TIN fall into one of these categories: drug toxicity,
heavy metals, metabolic disorders, hereditary disorders,
miscellaneous disorders, idiopathic, immunologic mechanisms, anti-tubular basement membrane antibodies, immune complexes, hypersensitivity, and cellular
pathomechanisms.4 Regarding the latter, recent, exciting
molecular discoveries have evinced some genetic tubulointerstitial disorders such as uromodulin disease4 and
juvenile nephronophthisis.5 These are extremely rare
and progressive disorders, and family history and genetic
analysis are crucial to diagnosis.
Because no diagnostic pattern exists for acute TIN, it is
not always considered early in the differential diagnosis
of AKI.6,7 Drugs such as proton pump inhibitors6 and antibiotics7 induce most acute cases of TIN, and the common

reﬂex is to suspect the most recent additions to the medical
armamentarium and alter the medication regimen in hope
of self-amelioration of the problem. Kidney biopsies
certainly can be carried out more frequently to establish
the diagnosis, but there is an inertia among most to do
so. When biopsies are done, acute TIN will be evident in
one-tenth of cases or more.3 After acute TIN is established,
withdrawal of the putative, offending agent should be followed by glucocorticoid administration, even when no
conﬁrmatory biopsy is available. Although this maneuver
may prove salutary by mitigating renal ﬁbrogenesis and
progression to chronic tubulointerstitial disease, resistance
to therapy prevails here. Is this resistance due to fear of
steroid-induced side effects or something else?
There are now intriguing data supporting the view that
early glucocorticoid administration results in superior
outcomes, and without induction of severe, untoward effects. Prendecki and associates examined biopsies from
187 patients in a 14-year retrospective analysis.8 Eightyfour percent (n¼158) received steroids and 16% (n¼29)
were managed conservatively. These 29 participants
were matched to 29 steroid-treated individuals to avoid
selection bias and before analysis. After 24 months of
observation, the steroid-treated group had an estimated
glomerular ﬁltration rate of 43 mL/min/1.73 m2 that was
signiﬁcantly greater than those untreated at 24 mL/min/
1.73 m2 (P , 0.01). In terms of dialysis dependence at
the 24-month end point, only 3.2% of steroid-treated patients required maintenance dialysis vs. 20.6%
(P , 0.002). This study is essentially a nested case-control
study. Therefore, the impact of confounding or bias,
particularly selection bias, on the outcomes cannot be
entirely excluded. Further testing of the Prendecki observations with a randomized, controlled trial is warranted.
Attenuation of renal ﬁbrosis by glucocorticoids may
retard the transition from acute to progressive and chronic
tubulointerstitial inﬂammation with ﬁbrosis. The inhibition of ﬁbrogenesis promotes normal proximal tubular
functions, including the secretion of toxins from peritubular capillaries, receipt of nutrients from the capillary
Ó 2017 by the National Kidney Foundation, Inc. All rights reserved.
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network, and transport of solutes to the circulation.9
Generally, in drug-induced acute TIN, treatment should
be delayed no longer than two weeks following clinical
diagnosis and withdrawal of the offending agent. Hopefully, in the near-term, small molecule-targeting of various
interstitial cells such as perivascular pericytes will provide
novel means to impede tubulointerstitial ﬁbrosis.10,11
Thus, a somewhat algorithmic, clinical approach to tubulointerstitial disease has emerged, but it is imperative
to acknowledge the dynamic interplay of the intrinsic
components of this long underappreciated and largest
of kidney compartments. Combined with the kidney
tubules and vascular components, the interstitium
becomes the tubulointerstitium. However, the kidney
interstitial compartment or interstitium has been
deﬁned by Lemley and Kriz12 as the intertubular, extraglomerular, extravascular space of the kidney bounded
topologically by tubular and vascular basement membranes. The interstitium also includes the extraglomerular mesangium, periarterial connective tissues,
and lymphatics. Polkissen cells, also referred to as cells
of Goormagtigh and lacis cells, are found near the
vascular pole beneath the afferent arteriolar endothelia
and occupy the space between the vasculature and the
macula densa. These ﬁbrillar pericytes likely participate
in kidney autoregulatory responses and possibly in
erythropoietin secretion.
The periarterial connective tissue sheaths represent the
scaffolding upon which the interstitial vasculature, vasa
recta and veins, and lymphatics are maintained. Here,
the vital solute exchanges occur that we take for granted
as passage from tubular lumina to vessels attributable to
the hydrostatic pressure gradient that drives solute from
the interstitium to the hilum. Note that there are no medullary lymphatics, and thus, there are two kidney interstitia, cortical, and medullary. This arrangement facilitates
countercurrent medullary solute trapping, thereby establishing in part the corticomedullary osmotic gradient.
The glycosaminoglycan content of the interstitium is relatively high, too, and provides the microenvironment in
which tubulovascular structures equilibrate with each
other, that is, this is a water- and solute-restricted space.
The interstitium houses multiple cell types, extracellular
matrix, and interstitial ﬂuid.9 The proximal tubular cells
that constitute most cells of the kidney tubular compartment may directly interact with the interstitium through
paracrine and juxtacrine mechanisms. They are semiprofessional antigen-presenting cells and elaborate numerous
growth factors and cytokines.10 Therefore, by virtue of
their proximity to the interstitium, these cells may participate, as bystander or inciting party, in multiple types of
inﬂammatory insults within the tubulointerstitium. Proximal tubular cells are exposed to inﬂammatory and immunological stimuli on their tubular and basolateral aspects.
These cells are inﬂuenced by a host of autacoids and produce their own growth factors, metalloproteinases and inhibitors thereof, and cytokines, including transforming
growth factor-beta.11 The consequent cell-matrix interactions may ultimately determine ﬁbroblast dynamics that
hasten, stabilize, or abolish extracellular matrix produc-

tion. One of the best known and experimentally proven
examples is the inﬂuence of a high-glucose environment
on proximal tubular epithelia, whereby hypertrophying
cells transform to a matrix-producing phenotype while
experiencing apoptosis.11 Less is known how the more
distal cells of the tubular compartment interact with the
neighboring interstitium.
Interstitial ﬁbroblasts have been the subject of intense
scrutiny for over three decades, and are considered among
the prototypical “interstitial” cells. These mesenchymal,
nonvascular, noninﬂammatory, nonepithelial cells are the
most prevalent residents of the interstitium.13 Fibroblasts
have speciﬁc cell markers and are distinguishable from
non-ﬁbroblastic cells of renal mesenchymal origin, for
example, pericytes, myoﬁbroblasts, vascular smooth
muscle cells, and stem cells. Historically, this had been
problematic, and ﬁbroblasts were identiﬁed as those cells
that were not the cells that had identiﬁable cell markers.
Fibroblasts and myoﬁbroblasts, derived from proto-myoﬁbroblasts that differentiated from ﬁbroblasts or from
circulating ﬁbrocytes,13,14 express matrix-promoting and
-degrading proteins such as zinc-dependent matrix
metalloproteinases and their tissue inhibitors, i.e., tissue
inhibitors of metalloproteinases. The net expression of
these counteracting proteins ultimately determines net
matrix accumulation or degradation of ﬁbrillar collagens
I and III within the tubulointerstitium, which is the
preeminent prognosticator of renal longevity–an
observation ﬁrst espoused by Schainuck et al.14 Nearly
ﬁve decades ago, he and colleagues demonstrated in 70 kidney biopsies that alterations in glomerular, tubular, vascular,
and interstitial compartments conformed to those of simultaneously measured glomerular ﬁltration rates, effective kidney plasma ﬂows, and concentrating and acidifying
capacities, irrespective of the form of kidney disease. Quite
unexpectedly, the investigators concluded that “impaired
kidney function was most closely related to changes in the
tubules and in the interstitium”—a truism now known to all.
In the kidney cortex, interstitial ﬁbroblasts are considered a source of endogenous erythropoietin production,
with the oxygen sensor intrinsic to these cells that express
messenger RNAs for erythropoietin and hypoxiainducible factor subunits 1-alpha and 2-alpha or another
peritubular cell juxtaposed to hypoxic blood ﬂow. (18)15
In addition, putative ﬁbroblast adenosine production
within the interstitium increases during hypoxic conditions. Fibroblasts, due to their tubular apposition, can
mediate the conversion of tubular adenosine monophosphate (50 -adenylic acid) to adenosine via intrinsic ecto-50 nucleotidase activity. The metabolic consequence of
intrarenally active adenosine is to lessen overall renal
workload during periods of metabolic stress by reducing
sodium reclamation and afferent arteriolar vasoconstriction, with limitation of ultraﬁltration.
Aside from ﬁbroblasts and myoﬁbroblasts the interstitium also contains resident mast cells, macrophages, lymphocytes, lymphatic endothelial cells, and dendritic cells
(DCs). Mast cells are rare in the normal kidney, but have
been associated with both proﬁbrotic and antiﬁbrotic actions. They play a vital role in the kidney ﬁbrosis of
Adv Chronic Kidney Dis. 2017;24(2):51-54
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obstructive uropathy during rodent unilateral obstruction.16 Macrophages are the oldest cells of hematopoietic
lineages. Migration of monocytes from the circulation to
the kidneys provides the few interstitial macrophages of
the normal kidney. Inﬂammatory foci and mediators recruit monocytes to the kidney in glomerular and tubulointerstitial disorders, with consequent differentiation into a
prototypical inﬂammatory M1 or reparative M2 phenotype.17 Type II major histocompatibility complex antigen
expression may ensue during the M1 transformation.
Overall, the balance between M1/M2 phenotypic expression and modulating interactions with T lymphocytes, ﬁbroblasts, and DCs via growth factors, cytokines, and
other microenvironmental cues dictates in part the extent
of renal ﬁbrogenesis and progression of chronic kidney
disease.
Note that ﬁbroblasts are not ﬁbrocytes,18,19 which are
derived from leukocytes. Fibrocytes, following
migration to the tubulointerstitium, may also participate
in the processes of interstitial ﬁbrosis and tubular
atrophy. These cells are typically identiﬁed in injured
kidneys and are present in nephrogenic systemic
ﬁbrosis.19 Resident kidney medullary ﬁbroblast-like interstitial cells are found along the renal medulla among the
vasa recta, Henle’s thin limb, and medullary collecting
ducts. Abundant lipid cytoplasmic droplets of triglycerides, cholesterol esters, and free long-chain fatty acids
including arachidonic acid are contained in these cells.
These medullary interstitial cells express cyclooxygenase-2 and are involved in prostanoid synthesis. Intracellular lipid droplets are altered by varying salt and water
intake, implying a role for these cells in normal and aberrant kidney physiology.20
The spotlight has recently been aimed at the DC. DCs
are antigen-collecting cells, well-characterized in the
immunology literature, mature in the interstitium
following their sojourn as bone marrow–derived precursor cells, a process requiring expression of the C-X3-C
motif chemokine receptor 1, CX3CR1.21 In the interstitial
compartment, DCs serve a sentinel role in the kidney,2 interacting with T cells residing within the interstitial
lymphatic network and probing for foreign antigen(s).
The relationship of DCs to interstitial mononuclear cells
is more intimate than previously thought, and DCs may
represent dichotomously differentiated cells from the
same monocyte lineage. DCs may also be recipients of
tubular lumen antigens presented by proximal tubular
cells, which constitutively express major histocompatibility complex class II antigens.22 Migration of DCs to the
glomerular compartment in nephrotoxic nephritis,22 a
glomerulonephritis, represents one mechanism among
many of tubuloglomerular crosstalk and injury within
the tubulointerstitium following glomerular injury.11
Weakly interacting massive particles have been
recently theorized as the major, if not only, constituent
of dark matter,1 but the incredible, galaxial instruments such as the Laser Interferometer GravitationalWave Observatory housed at the California Institute of
Technology and the Massachusetts Institute of Techno-

logy constructed to explore such postulates must resolve
signals from distances incomprehensible and over eons.
Fortunately, for us, our earth-bound kidney pathologists
and scientists have begun to resolve the mysteries of tubulointerstitial dark matter. To explore and comprehend
this dark matter in greater depth, you, the reader, must
now engage.
About Dark Matter: “I’m sorry I know so little. I’m
sorry we all know so little. But that’s kind of the
fun, isn’t it?.”
— Vera Rubin (2009)
Jerry Yee, MD
Editor-in-Chief
Henry Ford Hospital
Wayne State University
Detroit, MI
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